Press release
Acute Pulmonary Embolism Treatment Market Size in the 7MM is expected to grow a significant CAGR by 2032, estimates DelveInsight | Akura Medical, Angiodynamics Inc. Penumbra Inc., Agen Biomedical, Daiichi Sankyo, Boston Scientific Corporation, Tasly Bioph
Acute Pulmonary Embolism Market
Discover Key Insights into the Acute Pulmonary Embolism Market with DelveInsight's In-Depth Report @ Acute Pulmonary Embolism Market Size - https://www.delveinsight.com/sample-request/acute-pulmonary-embolism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Acute Pulmonary Embolism Market Report
• In February 2025:- Akura Medical:- This study is a prospective, single-arm, non-randomized, interventional, multicenter feasibility study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subjects with acute pulmonary embolism (PE).
• In February 2025:- Penumbra Inc.:- The primary objective of this trial is to evaluate the safety and efficacy of treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy with the Indigo Aspiration System for the treatment of intermediate-high risk acute pulmonary embolism (PE).
• In February 2025:- Boston Scientific Corporation:- This is a multi-center, single arm, prospective, observational, real-world study.To collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.
• In February 2025:- Neptune Medical:- This study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of acute pulmonary embolism. The Vertex Pulmonary Embolectomy System is intended for the non-surgical removal of emboli and thrombi from blood vessels as a means for treating pulmonary embolism.
• In February 2025:- Argon Medical Devices:- To evaluate the safety and efficacy of the CleanerTM Pro Thrombectomy System for aspiration thrombectomy in patients with acute pulmonary embolism (PE).
• The increase in Acute Pulmonary Embolism Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Acute Pulmonary Embolism Market is anticipated to witness growth at a considerable CAGR.
• The leading Acute Pulmonary Embolism Companies such as Akura Medical, Angiodynamics Inc. Penumbra Inc., Agen Biomedical, Daiichi Sankyo, Boston Scientific Corporation, Tasly Biopharmaceuticals Co., Ltd., Echosense Ltd, Magneto Thrombectomy Solutions, Eisai Inc., and others.
• Promising Acute Pulmonary Embolism Therapies such as Anticoagulation, DS-9231, Recombinant Human Prourokinase, Alteplase, Tinzaparin, Acenocoumarol, Inhaled Nitric Oxide and others.
Discover which therapies are expected to grab the Acute Pulmonary Embolism Market Share @ Acute Pulmonary Embolism Market Outlook- https://www.delveinsight.com/sample-request/acute-pulmonary-embolism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Acute Pulmonary Embolism Epidemiology Insights
The epidemiology section of Acute Pulmonary Embolism offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Acute Pulmonary Embolism Epidemiology trends @ Acute Pulmonary Embolism Prevalence- https://www.delveinsight.com/sample-request/acute-pulmonary-embolism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Acute Pulmonary Embolism Drugs Market
The Acute Pulmonary Embolism Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Acute Pulmonary Embolism signaling in Acute Pulmonary Embolism are likely to uncover new therapeutic targets and further expand treatment options for patients.
Acute Pulmonary Embolism Treatment Market Landscape
The Acute Pulmonary Embolism treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Acute Pulmonary Embolism has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Acute Pulmonary Embolism treatment guidelines, visit @ Acute Pulmonary Embolism Treatment Market Landscape- https://www.delveinsight.com/sample-request/acute-pulmonary-embolism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Acute Pulmonary Embolism Market Outlook
The report's outlook on the Acute Pulmonary Embolism market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Acute Pulmonary Embolism therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Acute Pulmonary Embolism drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders.
Acute Pulmonary Embolism Drugs Uptake
The drug chapter of the Acute Pulmonary Embolism report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Acute Pulmonary Embolism.
Major Acute Pulmonary Embolism Companies
Akura Medical, Angiodynamics Inc. Penumbra Inc., Agen Biomedical, Daiichi Sankyo, Boston Scientific Corporation, Tasly Biopharmaceuticals Co., Ltd., Echosense Ltd, Magneto Thrombectomy Solutions, Eisai Inc and others.
Learn more about the FDA-approved drugs for Acute Pulmonary Embolism @ Drugs for Acute Pulmonary Embolism Treatment- https://www.delveinsight.com/sample-request/acute-pulmonary-embolism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Acute Pulmonary Embolism Market Report
• Coverage- 7MM
• Acute Pulmonary Embolism Companies- Akura Medical, Angiodynamics Inc. Penumbra Inc., Agen Biomedical, Daiichi Sankyo, Boston Scientific Corporation, Tasly Biopharmaceuticals Co., Ltd., Echosense Ltd, Magneto Thrombectomy Solutions, Eisai Inc. and others.
• Acute Pulmonary Embolism Therapies- Anticoagulation, DS-9231, Recombinant Human Prourokinase, Alteplase, Tinzaparin, Acenocoumarol, Inhaled Nitric Oxide and others.
• Acute Pulmonary Embolism Market Dynamics: Acute Pulmonary Embolism Market Drivers and Barriers
• Acute Pulmonary Embolism Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Acute Pulmonary Embolism Drugs in development @ Acute Pulmonary Embolism Clinical Trials Assessment- https://www.delveinsight.com/sample-request/acute-pulmonary-embolism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Acute Pulmonary Embolism Market Overview at a Glance
4. Executive Summary of Acute Pulmonary Embolism
5. Key Events
6. Acute Pulmonary Embolism Epidemiology and Market Methodology
7. Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
10. Acute Pulmonary Embolism Marketed Therapies
11. Acute Pulmonary Embolism Emerging Therapies
12. Acute Pulmonary Embolism: Market Analysis
13. KOL Views
14. SWOT Analysis
15. Unmet Needs
16. Market Access
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
List of Top Selling Market Research Reports in 2025
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Phototherapies for psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Vascular access devices market- https://www.delveinsight.com/report-store/vascular-access-device-market
NK cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Ventral hernia market- ttps://www.delveinsight.com/report-store/hernia-repair-devices-market
Medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market
Total knee arthroplasty market- https://www.delveinsight.com/report-store/knee-reconstruction-devices-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Baricose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Pouchitis market- https://www.delveinsight.com/report-store/pouchitis-market
Diabetic wound market- https://www.delveinsight.com/report-store/diabetic-wounds-market
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Transcatheter treatment market- https://www.delveinsight.com/report-store/transcatheter-treatment-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Chronic neuropathic pain market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Pulmonary Embolism Treatment Market Size in the 7MM is expected to grow a significant CAGR by 2032, estimates DelveInsight | Akura Medical, Angiodynamics Inc. Penumbra Inc., Agen Biomedical, Daiichi Sankyo, Boston Scientific Corporation, Tasly Bioph here
News-ID: 3889935 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
